Photo from Matthijs Van Meerveld/Twitter
Jan 29, 2024, 11:02
Matthijs Van Meerveld: No test, no treatment
Matthijs Van Meerveld, Associate Vice President of Global Head of Access Policy & Patient Advocacy, Oncology at MENARINI Group, shared a post on LinkedIn:
“No test, no treatment. Menarini Group CEO, Elcin Barker Ergun, talks about how removing the barriers to biomarker testing can help create a future in which more people survive cancer:
‘European policymakers, healthcare providers, researchers, and pharmaceutical companies must join forces to create a comprehensive framework that facilitates widespread access to biomarker testing’.
View additional information.
Source: Matthijs Van Meerveld/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 09:22
Dec 21, 2024, 09:06
Dec 21, 2024, 09:00
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29
Dec 21, 2024, 08:12